Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism

Brain

Volumn 130, Issue 1, 2007, Pages 265-275

  Rolland, Anne Sophie ^a,b,c   Herrero, Maria Trinidad ^d   Garcia Martinez, Virginia ^d   Ruberg, Merle ^a,b,c   Hirsch, Etienne C ^a,b,c   François, Chantal ^a,b,c  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d UNIVERSITY OF MURCIA   (Spain)

Author keywords

Cytochrome oxidase; Metabolic activity; Non human primates; Parkinson's disease; Thalamus

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CYTOCHROME C OXIDASE; MESSENGER RNA; OXIDOPAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BASAL GANGLION; BRAIN METABOLISM; CEREBELLUM CORTEX; COMPARATIVE STUDY; CONTROLLED STUDY; GENOME; GLOBUS PALLIDUS; MALE; MONKEY; MOTOR CORTEX; NERVE CELL; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; RAT; STRIATONIGRAL DEGENERATION; SUBSTANTIA NIGRA; THALAMOCORTICAL TRACT; THALAMUS;

EID: 33845906368     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awl337     Document Type: Article

References (70)

1. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989; 12: 366-75.
2. Armstrong E. Limbic thalamus: anterior and mediodorsal nuclei. In: Paxinos G, editor. The human nervous system. New York: Academic Press; 1990. p. 469-81.
3. Aumann TD, Rawson JA, Pichitpornchai C, Horne MK. Projections from the cerebellar interposed and dorsal column nuclei to the thalamus in the rat: a double anterograde labelling study. J Comp Neurol 1996; 368: 608-19.
4. Aymerich MS, Barroso-Chinea P, Perez-Manso M, Munoz-Patino AM, Moreno-Igoa M, Gonzalez-Hernandez T, et al. Consequences of unilateral nigrostriatal denervation on the thalamostriatal pathway in rats. Eur J Neurosci 2006; 23: 2099-108.
5. Beckstead RM, Domesick VB, Nauta WJ. Efferent connections of the substantia nigra and ventral tegmental area in the rat. Brain Res 1979; 175: 191-217.
6. Benabid AL, Pollak P, Gervason C, Hoffmann D, Gao DM, Hommel M, et al. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 1991; 337: 403-6.
7. Bentivoglio M, van der KD, Kuypers HG. The organization of the efferent projections of the substantia nigra in the rat. A retrograde fluorescent double labeling study. Brain Res 1979; 174: 1-17.
8. Blanchard V, Chritin M, Vyas S, Savasta M, Feuerstein C, Agid Y, et al. Long-term induction of tyrosine hydroxylase expression: compensatory response to partial degeneration of the dopaminergic nigrostriatal system in the rat brain. J Neurochem 1995; 64: 1669-79.
9. Brownell AL, Canales K, Chen YI, Jenkins BG, Owen C, Livni E, et al. Mapping of brain function after MPTP-induced neurotoxicity in a primate Parkinson's disease model. Neuroimage 2003; 20: 1064-75.
10. Chevalier G, Deniau JM. Inhibitory nigral influence on cerebellar evoked responses in the rat ventromedial thalamic nucleus. Exp Brain Res 1982; 48: 369-76.
11. Crossman AR, Clarke CE, Boyce S, Robertson RG, Sambrook MA. MPTP-induced parkinsonism in the monkey: neurochemical pathology, complications of treatment and pathophysiological mechanisms. Can J Neurol Sci (Winnipeg) 1987; 14: 428-35.
12. DeLong MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990; 13: 281-5.
13. Deniau JM, Kita H, Kitai ST. Patterns of termination of cerebellar and basal ganglia efferents in the rat thalamus. Strictly segregated and partly overlapping projections. Neurosci Lett 1992; 144: 202-6.
14. Deschenes M, Bourassa J, Doan VD, Parent A. A single-cell study of the axonal projections arising from the posterior intralaminar thalamic nuclei in the rat. Eur J Neurosci 1996; 8: 329-43.
15. Elsworth JD, Deutch AY, Redmond J, Sladek J, Roth RH. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF. Brain Res 1987; 415: 293-9.
16. Faull RL, Mehler WR. The cells of origin of nigrotectal, nigrothalamic and nigrostriatal projections in the rat. Neuroscience 1978; 3: 989-1002.
17. Feger J, Crossman AR. Identification of different subpopulations of neostriatal neurones projecting to globus pallidus or substantia nigra in the monkey: a retrograde fluorescence double-labelling study. Neurosci Lett 1984; 49: 7-12.
18. Finkelstein DI, Reeves AK, Horne MK. An electron microscopic tracer study of the projections from entopeduncular nucleus to the ventrolateral nucleus of the rat. Neurosci Lett 1996; 211: 33-6.
19. Fontaine B, Sassoon D, Buckingham M, Changeux JP. Detection of the nicotinic acetylcholine receptor alpha-subunit mRNA by in situ hybridization at neuromuscular junctions of 15-day-old chick striated muscles. EMBO J 1988; 7: 603-9.
20. Freeman A, Ciliax B, Bakay R, Daley J, Miller RD, Keating G, et al. Nigrostriatal collaterals to thalamus degenerate in parkinsonian animal models. Ann Neurol 2001; 50: 321-9.
21. Gerfen CR, Staines WA, Arbuthnott GW, Fibiger HC. Crossed connections of the substantia nigra in the rat. J Comp Neurol 1982; 207: 283-303.
22. Gimenez-Amaya JM, McFarland NR, de las HS, Haber SN. Organization of thalamic projections to the ventral striatum in the primate. J Comp Neurol 1995; 354: 127-49.
23. Gnanalingham KK, Milkowski NA, Smith LA, Hunter AJ, Jenner P, Marsden CD. Short and long-term changes in cerebral [14C]-2-deoxyglucose uptake in the MPTP-treated marmoset: relationship to locomotor activity. J Neural Transm Gen Sect 1995; 101: 65-82.
24. Goldberg JA, Boraud T, Maraton S, Haber SN, Vaadia E, Bergman H. Enhanced synchrony among primary motor cortex neurons in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine primate model of Parkinson's disease. J Neurosci 2002; 22: 4639-53.
25. Graybiel AM, Ragsdale CW Jr. Histochemically distinct compartments in the striatum of human, monkeys and cat demonstrated by acetylthiocholinesterase staining. Proc Natl Acad Sci USA 1978; 75: 5723-6.
26. Guehl D, Pessiglione M, Francois C, Yelnik J, Hirsch EC, Feger J, et al. Tremor-related activity of neurons in the 'motor' thalamus: changes in firing rate and pattern in the MPTP vervet model of parkinsonism. Eur J Neurosci 2003; 17: 2388-400.
27. Hazrati LN, Parent A. Projection from the external pallidum to the reticular thalamic nucleus in the squirrel monkey. Brain Res 1991; 550: 142-6.
28. Hevner RF, Wong-Riley MT. Neuronal expression of nuclear and mitochondrial genes for cytochrome oxidase (CO) subunits analyzed by in situ hybridization: comparison with CO activity and protein. J Neurosci 1991; 11: 1942-58.
29. +-ATPase. Neurosci Lett 1992; 138: 188-92.
30. Hirsch EC, Perier C, Orieux G, Francois C, Feger J, Yelnik J, et al. Metabolic effects of nigrostriatal denervation in basal ganglia. Trends Neurosci 2000; 23: S78-85.
31. Ilinsky IA, Kultas-Ilinsky K. Sagittal cytoarchitectonic maps of the Macaca mulatta thalamus with a revised nomenclature of motor-related nuclei validated by observations on their connectivity. J Comp Neurol 1987; 262: 331-64.
32. Ilinsky IA, Jouandet ML, Goldman-Rakic PS. Organisation of the nigrothalamocortical system in the rhesus monkey. J Comp Neurol 1985; 236: 315-30.
33. Jones EG. The thalamus. New York: Plenum Press; 1985.
34. Kha HT, Finkelstein DI, Pow DV, Lawrence AJ, Horne MK. Study of projections from the entopeduncular nucleus to the thalamus of the rat. J Comp Neurol 2000; 426: 366-77.
35. Kha HT, Finkelstein DI, Tomas D, Drago J, Pow DV, Horne MK. Projections from the substantia nigra pars reticulata to the motor thalamus of the rat: single axon reconstructions and immunohistochemical study. J Comp Neurol 2001; 440: 20-30.
36. Kultas-Ilinsky K, Ilinsky IA. Fine structure of the magnocellular subdivision of the ventral anterior thalamic nucleus (VAmc) of Macaca mulatta: II Organization of nigrothalamic afferents as revealed with EM autoradiography. J Comp Neurol 1990; 294: 479-89.
37. Lees AJ, Blackburn NA, Campbell VL. The nighttime problems of Parkinson's disease. Clin Neuropharmacol 1988; 11: 512-9.
38. Lozano AM, Lang AE. Pallidotomy for Parkinson's disease. Neurosurg Clin N Am 1998; 9: 325-36.
39. Luquin MR, Laguna J, Herrero MT, Obeso JA. Behavioral tolerance to repeated apomorphine administration in parkinsonian monkeys. J Neurol Sci 1993; 114: 40-4.
40. McFarland NR, Haber SN. Convergent inputs from thalamic motor nuclei and frontal cortical areas to the dorsal striatum in the primate. J Neurosci 2000; 20: 3798-813.
41. Mitchell BD, Cauller LJ. Corticocortical and thalamocortical projections to layer I of the frontal neocortex in rats. Brain Res 2001; 921: 68-77.
42. Mitchell IJ, Clarke CE, Boyce S, Robertson RG, Peggs D, Sambrook MA, et al. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4 phenyl-12,3,6- tetrahydropyridine. Neuroscience 1989; 32: 213-26.
43. Molnar GF, Pilliar A, Lozano AM, Dostrovsky JO. Differences in neuronal firing rates in pallidal and cerebellar receiving areas of thalamus in patients with Parkinson's disease, essential tremor, and pain. J Neurophysiol 2005; 93: 3094-101.
44. Narabayashi H, Ohye C. Nucleus ventralis intermedius of human thalamus. Trans Am Neurol Assoc 1974; 99: 232-3.
45. Narabayashi H, Ohye C. Pathological tremor: its generating mechanism, treatment. In: Yahr MD, editor. Current concept of Parkinson disease and related disorders. Excerpta Medica; 1983. p. 47-55.
46. Naudon L, Raisman-Vozari R, Edwards RH, Leroux-Nicollet I, Peter D, Liu Y, et al. Reserpine affects differentially the density of the vesicular monoamine transporter and dihydrotetrabenazine binding sites. Eur J Neurosci 1996; 8: 842-6.
47. Ohye C, Shibazaki T. Lesioning the thalamus for dyskinesia. Stereotact Funct Neurosurg 2001; 77: 33-9.
48. Olszewski J. The thalamus of the macaca mulatta. An atlas for use with the stereotaxic instruments. Basel: Karger; 1952.
49. Orieux G, Francois C, Feger J, Yelnik J, Vila M, Ruberg M, et al. Metabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson's disease. Neuroscience 2000; 97: 79-88.
50. Orieux G, Francois C, Feger J, Hirsch EC. Consequences of dopaminergic denervation on the metabolic activity of the cortical neurons projecting to the subthalamic nucleus in the rat. J Neurosci 2002; 22: 8762-70.
51. Ovadia A, Zhang Z, Gash DM. Increased susceptibility to MPTP toxicity in middle-aged rhesus monkeys. Neurobiol Aging 1995; 16: 931-7.
52. Page RD, Sambrook MA, Crossman AR. Thalamotomy for the alleviation of levodopa-induced dyskinesia: experimental studies in the 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine-treated parkinsonian monkey. Neuroscience 1993; 55: 147-65.
53. Palombo E, Porrino LJ, Bankiewicz KS, Crane AM, Kopin IJ, Sokoloff L. Administration of MPTP acutely increases glucose utilization in the substantia nigra of primates. Brain Res 1988; 453: 227-34.
54. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 4th edn. London: Academic Press, 1998.
55. Pelled G, Bergman H, Goelman G. Bilateral overactivation of the sensorimotor cortex in the unilateral rodent model of Parkinson's disease - a functional magnetic resonance imaging study. Eur J Neurosci 2002; 15: 389-94.
56. Percheron G, Francois C, Talbi B, Yelnik J, Fenelon G. The primate motor thalamus. Brain Res Brain Res Rev 1996; 22: 93-181.
57. Pessiglione M, Guehl D, Rolland AS, Francois C, Hirsch EC, Feger J, et al. Thalamic neuronal activity in dopamine-depleted primates: evidence for a loss of functional segregation within basal ganglia circuits. J Neurosci 2005; 25: 1523-31.
58. Pinault D, Deschenes M. Anatomical evidence for a mechanism of lateral inhibition in the rat thalamus. Eur J Neurosci 1998; 10: 3462-9.
59. Sanchez-Gonzalez MA, Garcia-Cabezas MA, Rico B, Cavada C. The primate thalamus is a key target for brain dopamine. J Neurosci 2005; 25: 6076-83.
60. Schneider JS, Rothblat DS. Alterations in intralaminar and motor thalamic physiology following nigrostriatal dopamine depletion. Brain Res 1996; 742: 25-33.
61. Schwartzman RJ, Alexander GM, Ferraro TN, Grothusen JR, Stahl SM. Cerebral metabolism of parkinsonian primates 21 days after MPTP. Exp Neurol 1988; 102: 307-13.
62. Sherman SM. Interneurons and triadic circuitry of the thalamus. Trends Neurosci 2004; 27: 670-5.
63. Sidibe M, Smith Y. Differential synaptic innervation of striatofugal neurones projecting to the internal or external segments of the globus pallidus by thalamic afferents in the squirrel monkey. J Comp Neurol 1996; 365: 445-65.
64. Steiner H, Kitai ST. Regulation of rat cortex function by D1 dopamine receptors in the striatum. J Neurosci 2000; 20: 5449-60.
65. Steriade M, Jones EG, McCormick DA. Thalamus. Volume I, organization and function. Oxford: Elsevier Science; 1997.
66. Vila M, Herrero MT, Levy R, Faucheux B, Ruberg M, Guillen J, et al. Consequences of nigrostriatal denervation on the gamma-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes. Neurology 1996; 46: 802-9.
67. Vila M, Levy R, Herrero MT, Ruberg M, Faucheux B, Obeso JA, et al. Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA. J Neurosci 1997; 17: 765-73.
68. Vila M, Perier C, Feger J, Yelnik J, Faucheux B, Ruberg M, et al. Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic and electrophysiological measurements. Eur J Neurosci 2000; 12: 337-44.
69. Wong-Riley MT. Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci 1989; 12: 94-101.
70. Wong-Riley MT, Merzenich MM, Leake PA. Changes in endogenous enzymatic reactivity to DAB induced by neuronal inactivity. Brain Res 1978; 141: 185-92.